These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1338282

  • 1. Elevated expression of thymidylate synthase in doxorubicin resistant human non small cell lung carcinomas.
    Volm M, Mattern J.
    Anticancer Res; 1992; 12(6B):2293-6. PubMed ID: 1338282
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
    Ibe T, Shimizu K, Nakano T, Kakegawa S, Kamiyoshihara M, Nakajima T, Kaira K, Takeyoshi I.
    J Surg Oncol; 2010 Jul 01; 102(1):11-7. PubMed ID: 20578072
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ.
    Am J Clin Oncol; 2009 Feb 01; 32(1):38-43. PubMed ID: 19194123
    [Abstract] [Full Text] [Related]

  • 7. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
    Miyamoto H, Morio A, Izumi H, Yamazaki A, Wang Z, Futagawa T, Sonobe S.
    Anticancer Res; 2003 Feb 01; 23(5b):4153-6. PubMed ID: 14666617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer.
    Volm M, Pommerenke EW.
    Anticancer Res; 1995 Feb 01; 15(2):463-6. PubMed ID: 7763022
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, Tsuyuguchi M, Kimura S, Sumitomo M, Monden Y.
    Anticancer Res; 2005 Feb 01; 25(2A):923-30. PubMed ID: 15868929
    [Abstract] [Full Text] [Related]

  • 13. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
    Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE, Oie HK, Pass HI, Steinberg SM, Ghosh BC.
    Cancer Res; 1993 Nov 01; 53(21):5181-7. PubMed ID: 8221655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
    Takizawa M, Kawakami K, Obata T, Matsumoto I, Ohta Y, Oda M, Sasaki T, Watanabe G.
    Oncol Rep; 2006 Jun 01; 15(6):1533-9. PubMed ID: 16685392
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer.
    Jakobsen JN, Santoni-Rugiu E, Sørensen JB.
    J Cancer Res Clin Oncol; 2014 Apr 01; 140(4):645-52. PubMed ID: 24562672
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B, Lötterle H, Schanzenbächer U, Lah TT, Kalman E, Kayser K, Bülzebruck H, Schirren J, Krasovec M, Kos J, Spiess E.
    Br J Cancer; 1999 Oct 01; 81(3):510-9. PubMed ID: 10507778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.